New York City, NY -- (SBWIRE) -- 10/07/2013 -- StockMarketIntel.com issues a special report on the following stocks: Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY), Renren Inc (NYSE:RENN), Microsoft Corporation (NASDAQ:MSFT), Mast Therapeutics Inc (NYSEMKT:MSTX)
Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY) gained 1.95%, trading on 12M shares, to end the trade at $15.20. If we look at its trading history of the past 52 weeks, the share price suffered a low of $10.34 and was moved to the maximum level of $15.24. The stock changed hands in a range of $15.12 to $15.24, bringing its market capitalization to about $67.62 billion. Deutsche Telekom AG is a Germany-based integrated telecommunications provider offering its customers around the world a portfolio of services in the areas of telecommunications and information technology (IT). The Company diversifies its activities into three geographical segments: Germany, Europe and USA; as well as operates the Systems Solutions, and Group Headquarters & Shared Services operating segments.
What was the Moving Force behind DTEGY on Bullish Run? Read This Research Report
Renren Inc (NYSE:RENN) added 5.483%, to complete the trading session at $4.04, with a total volume of 7.92 million shares. The stock, on average, trades on a volume of 3.76 million shares. In the past 52 weeks, the share price has not declined below $2.52 and above $4.62. It floated in a range of $3.84 to $4.21. Its market capitalization now moved to about $1.50 billion. Renren Inc. operates real name social networking Internet platform in the People’s Republic of China. Its platform enables its users to connect and communicate with each other, share information and user-generated content, play online games, listen to music, shop for deals and a range of other features and services.
For How Long RENN will fight for Profitability? Read This Trend Analysis report
Microsoft Corporation (NASDAQ:MSFT) added 0.06% and was in a range of $33.62-$33.99 before closing at $33.88. The share price hit its 52-week low of $26.26 and $36.43 was the best price. The stock completed the day with a total volume of 33.08 million shares, versus an average volume of 62.99 million shares. Microsoft Corporation is engaged in developing, licensing and supporting a range of software products and services. The Company operates in five segments: Windows & Windows Live Division (Windows Division), Server and Tools, Online Services Division (OSD), Microsoft Business Division (MBD), and Entertainment and Devices Division (EDD).
For How Long MSFT Gloss will Attract Investors? Find out via this report
Mast Therapeutics Inc (NYSEMKT:MSTX) added 1.53%, bringing its market capitalization around $51.10 million. The total number of shares that changed hands during the session was 3.83 million shares, as compared to average trading volume of 1.40 million shares. The share price, after opening at $0.50, made a high of $0.51and hovered above $0.48 to end the day at $0.498. Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., is a development-stage company biopharmaceutical company focused on developing product candidates. The Company's product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has application in treating a range of diseases and conditions, such as complications arising from sickle cell disease.
Will MSTX Continue To Move Higher? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)